{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=on-label+facial+injection", "query": { "intervention": "on-label facial injection" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 11, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=on-label+facial+injection&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-15T22:47:38.070Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06161246", "title": "A Controlled Study on Pain Management With Injection of Botulinum Toxin for Glabellar Line Correction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Injection Site Discomfort" ], "interventions": [ { "name": "Vibrating Beauty Bar", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Galderma R&D", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 60, "start_date": "2023-10-23", "completion_date": "2024-02-15", "has_results": false, "last_update_posted_date": "2024-03-22", "last_synced_at": "2026-09-15T22:47:38.070Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT06161246" }, { "nct_id": "NCT06120140", "title": "Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Carcinoma, Non-Small-Cell Lung" ], "interventions": [ { "name": "Amivantamab IV", "type": "DRUG" }, { "name": "Amivantamab SC", "type": "DRUG" }, { "name": "Lazertinib", "type": "DRUG" }, { "name": "Doxycycline", "type": "DRUG" }, { "name": "Minocycline", "type": "DRUG" }, { "name": "Clindamycin", "type": "DRUG" }, { "name": "Chlorhexidine", "type": "DRUG" }, { "name": "Noncomedogenic skin moisturizer", "type": "OTHER" }, { "name": "Ruxolitinib", "type": "OTHER" }, { "name": "Tacrolimus", "type": "OTHER" }, { "name": "Zinc gluconate", "type": "DRUG" }, { "name": "Propranolol", "type": "DRUG" }, { "name": "Timolol", "type": "DRUG" }, { "name": "Clobetasol", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 305, "start_date": "2024-02-16", "completion_date": "2030-06-30", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-09-15T22:47:38.070Z", "location_count": 28, "location_summary": "Chandler, Arizona • Duarte, California • Fullerton, California + 25 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06120140" }, { "nct_id": "NCT07419854", "title": "Restoring Facial Volume After GLP-1 Weight Loss With Radiesse", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Volume Loss (Soft Tissue Ptosis or Atrophy )" ], "interventions": [ { "name": "Hyperdiluted Calcium Hydroxylapatite", "type": "DEVICE" }, { "name": "Calcium hydroxylapatite", "type": "DEVICE" }, { "name": "Calcium hydroxylapatite with integral lidocaine", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Kalpna Kay Durairaj, MD, FACS", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "21 Years to 65 Years" }, "enrollment_count": 48, "start_date": "2026-02-01", "completion_date": "2027-09", "has_results": false, "last_update_posted_date": "2026-09-09", "last_synced_at": "2026-09-15T22:47:38.070Z", "location_count": 1, "location_summary": "Pasadena, California", "locations": [ { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07419854" }, { "nct_id": "NCT05476679", "title": "Evaluation the Effects of Various Treatments on RZL-012-Induced Adverse Events", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Submental Fat" ], "interventions": [ { "name": "RZL-012", "type": "DRUG" }, { "name": "RZL-012+Lidacaine injection prior treatment", "type": "DRUG" }, { "name": "RZL-012+Medrol", "type": "DRUG" }, { "name": "RZL-012+Celecoxib+Zyrtec", "type": "DRUG" }, { "name": "RZL-012+facial and neck wrap", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Raziel Therapeutics Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 48, "start_date": "2022-09-25", "completion_date": "2023-06-12", "has_results": true, "last_update_posted_date": "2024-01-30", "last_synced_at": "2026-09-15T22:47:38.070Z", "location_count": 1, "location_summary": "Manhattan, New York", "locations": [ { "city": "Manhattan", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05476679" }, { "nct_id": "NCT04594213", "title": "Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)" ], "interventions": [ { "name": "NT 201", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merz North America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 362, "start_date": "2020-09-23", "completion_date": "2022-05-09", "has_results": true, "last_update_posted_date": "2024-05-08", "last_synced_at": "2026-09-15T22:47:38.070Z", "location_count": 12, "location_summary": "Encino, California • Newport Beach, California • San Diego, California + 7 more", "locations": [ { "city": "Encino", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Greenwood Village", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04594213" }, { "nct_id": "NCT06218251", "title": "A Study to Evaluate Participant Satisfaction and Natural Outcomes Following Administration of BOTOX Cosmetic Injections in Adult Participants for Treatment of Upper Facial Lines", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Upper Facial Lines" ], "interventions": [ { "name": "BOTOX", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2024-02-05", "completion_date": "2024-12-17", "has_results": true, "last_update_posted_date": "2025-11-24", "last_synced_at": "2026-09-15T22:47:38.070Z", "location_count": 7, "location_summary": "Birmingham, Alabama • San Francisco, California • Vista, California + 4 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Francisco", "state": "California" }, { "city": "Vista", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT06218251" }, { "nct_id": "NCT02465606", "title": "A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Lebrikizumab", "type": "DRUG" }, { "name": "Topical Corticosteroid Creams (Triamcinolone acetonide 0.1% and Hydrocortisone 2.5%)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 55, "start_date": "2015-07-30", "completion_date": "2016-05-30", "has_results": false, "last_update_posted_date": "2020-01-27", "last_synced_at": "2026-09-15T22:47:38.070Z", "location_count": 12, "location_summary": "Encino, California • Granada Hills, California • Mission Viejo, California + 9 more", "locations": [ { "city": "Encino", "state": "California" }, { "city": "Granada Hills", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT02465606" }, { "nct_id": "NCT05162300", "title": "Same-Day Combination of VI Peel and Botox for Correction of Sun Damage, Fine Lines and Wrinkles", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Photoaging", "Wrinkle", "Sun Damaged Skin" ], "interventions": [ { "name": "Same Day Intervention of VI Peel (Procedure) and Botulinum Toxin (Drug)", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Vitality Institute Medical Products", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "30 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "30 Years to 70 Years" }, "enrollment_count": 30, "start_date": "2021-12-08", "completion_date": "2022-02-01", "has_results": false, "last_update_posted_date": "2022-04-25", "last_synced_at": "2026-09-15T22:47:38.070Z", "location_count": 1, "location_summary": "Rancho Mirage, California", "locations": [ { "city": "Rancho Mirage", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05162300" }, { "nct_id": "NCT03559972", "title": "Study to Evaluate Efficacy and Tolerability of Two Topical Regimens in Subjects With Moderate to Severe Facial Photodamage Who Have Received Cosmetic Injections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Facial Photodamage" ], "interventions": [ { "name": "on-label facial injection", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "FEMALE", "summary": "30 Years and older · Female only" }, "enrollment_count": 40, "start_date": "2018-06-04", "completion_date": "2018-12-03", "has_results": false, "last_update_posted_date": "2019-01-30", "last_synced_at": "2026-09-15T22:47:38.070Z", "location_count": 2, "location_summary": "San Diego, California • Houston, Texas", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03559972" }, { "nct_id": "NCT01212809", "title": "Comparative Study of Reconstituted JUVÉDERM® Ultra vs COSMODERM® 1 for Lip and Cheek Lines, Folds or Wrinkles", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Intrinsic Aging of Skin" ], "interventions": [ { "name": "Juvéderm Ultra", "type": "DEVICE" }, { "name": "Cosmoderm 1", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Steven Fagien", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "25 Years to 70 Years" }, "enrollment_count": 30, "start_date": "2010-09", "completion_date": "2011-06", "has_results": false, "last_update_posted_date": "2011-09-12", "last_synced_at": "2026-09-15T22:47:38.070Z", "location_count": 1, "location_summary": "Boca Raton, Florida", "locations": [ { "city": "Boca Raton", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01212809" } ] }